100% Quality Guarantee
PhD-Level Technical Support
Key Features

Erenumab Biosimilar (CGRPR) Antibody (HDBS0148)

SKU HDBS0148
Antibody Type Biosimilar Reference Antibody
Applications IHC
Applications FC
Applications Drug Development
Applications Pharmacokinetics
Disease Area Cancer
Protein CGRPR
Reactivity Human
Host Species Human
Isotype IgG2
$569

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheet

Erenumab Biosimilar (CGRPR) Antibody (HDBS0148)

The Erenumab Biosimilar Anti-CGRP(R) Antibody offered by Assay Genie is a cutting-edge product designed for research involving the CGRP(R) receptor, a key player in migraine pathophysiology. This biosimilar antibody, derived from advanced biotechnology processes, is highly specific and shows strong binding affinity to the CGRP(R) receptor in human samples.With its validated efficacy in various experimental settings, including cell-based assays and protein analysis techniques, the Erenumab Biosimilar Anti-CGRP(R) Antibody is a powerful tool for investigating the role of CGRP signaling in migraine and other neurological disorders.

Its high sensitivity and precision make it an invaluable asset in drug development and pharmacological research aimed at targeting the CGRP pathway for therapeutic interventions.By providing researchers with a reliable and robust tool for studying CGRP signaling, this biosimilar antibody opens up new avenues for understanding the molecular mechanisms underlying migraine and offers potential insights for the development of novel treatments. Explore the possibilities with the Erenumab Biosimilar Anti-CGRP(R) Antibody from Assay Genie and unlock the secrets of CGRP-mediated pathways in neurological health.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose